Literature DB >> 15365631

[Staging of multiple myeloma with MRI: comparison to MSCT and conventional radiography].

A Baur-Melnyk1, M Reiser.   

Abstract

The staging of patients with multiple myeloma demands sensitive imaging methods for the assessment of the skeletal system. MRI allows for direct visualization of the bone marrow which exhibits five different infiltration patterns in multiple myeloma: 1. normal appearance of the bone marrow, 2. focal involvement, 3. homogeneous diffuse infiltration, 4. combined diffuse and focal infiltration, 5. "salt and pepper" pattern with inhomogeneous bone marrow signals due to multiple fat islands. The combination of T1w-SE and STIR sequences is best suited for detecting all infiltration patterns and for the differential diagnoses e. g. hemangiomas. With parallel imaging in MRI, acquisition times can be markedly reduced and whole-body screening of the bone marrow can be achieved within 30 min. MRI is superior to radiography for the detection of focal as well as diffuse infiltration. Multidetector computed tomography and especially 16- and 64-detector row scanners allow fast imaging with thin slice collimation and multiplanar reconstructions. With low-dose protocols, effective dose reduction can be achieved, so that radiation exposure is only slightly higher than that of a whole-body skeletal x-ray exam. Sensitivity of MSCT is markedly superior to conventional radiography. Due to the direct visualization of the bone marrow with MRI, MRI is superior in detecting early infiltrations with myeloma cells without osteolyses. In advanced multiple myeloma, CT on the other hand, enables for more precise assessment of bony destructions and fracture risk.

Entities:  

Mesh:

Year:  2004        PMID: 15365631     DOI: 10.1007/s00117-004-1103-z

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  23 in total

1.  [Magnetic resonance tomography in plasmacytoma: ranking of various sequences in diffuse and focal infiltration patterns].

Authors:  A Baur; A Stäbler; M Steinborn; P Schnarkowski; C Pistitsch; R Lamerz; R Bartl; M Reiser
Journal:  Rofo       Date:  1998-04

2.  Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates.

Authors:  A Stäbler; A Baur; R Bartl; R Munker; R Lamerz; M F Reiser
Journal:  AJR Am J Roentgenol       Date:  1996-10       Impact factor: 3.959

3.  Long-term survival in multiple myeloma.

Authors:  R A Kyle
Journal:  N Engl J Med       Date:  1983-02-10       Impact factor: 91.245

4.  Prognostic evaluation in multiple myeloma: an analysis of the impact of new prognostic factors.

Authors:  I Turesson; N Abildgaard; T Ahlgren; I Dahl; E Holmberg; M Hjorth; J L Nielsen; A Odén; C Seidel; A Waage; J Westin; F Wislöff
Journal:  Br J Haematol       Date:  1999-09       Impact factor: 6.998

5.  Stage I multiple myeloma: value of MR imaging of the bone marrow in the determination of prognosis.

Authors:  B C Van de Berg; F E Lecouvet; L Michaux; M Labaisse; J Malghem; J Jamart; B E Maldague; A Ferrant; J L Michaux
Journal:  Radiology       Date:  1996-10       Impact factor: 11.105

6.  Magnetic resonance imaging of the lower vertebral column in patients with multiple myeloma.

Authors:  F X Fruehwald; D Tscholakoff; B Schwaighofer; L Wicke; A Neuhold; H Ludwig; P C Hajek
Journal:  Invest Radiol       Date:  1988-03       Impact factor: 6.016

7.  Whole-body MRI using a rolling table platform for the detection of bone metastases.

Authors:  Thomas C Lauenstein; Lutz S Freudenberg; Susanne C Goehde; Stefan G Ruehm; Mathias Goyen; Silke Bosk; Jörg F Debatin; Jörg Barkhausen
Journal:  Eur Radiol       Date:  2002-03-08       Impact factor: 5.315

8.  Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR imaging.

Authors:  A Rahmouni; M Divine; D Mathieu; M Golli; T H Dao; N Jazaerli; M C Anglade; F Reyes; N Vasile
Journal:  AJR Am J Roentgenol       Date:  1993-05       Impact factor: 3.959

9.  MRI in the detection of malignant infiltration of bone marrow.

Authors:  R H Daffner; A R Lupetin; N Dash; Z L Deeb; R J Sefczek; R L Schapiro
Journal:  AJR Am J Roentgenol       Date:  1986-02       Impact factor: 3.959

10.  Risk of disease progression in asymptomatic multiple myeloma.

Authors:  M A Dimopoulos; A Moulopoulos; T Smith; K B Delasalle; R Alexanian
Journal:  Am J Med       Date:  1993-01       Impact factor: 4.965

View more
  11 in total

Review 1.  [Whole body MRI--diagnostic strategy of the future?].

Authors:  M Goyen; H-P Schlemmer
Journal:  Radiologe       Date:  2007-10       Impact factor: 0.635

Review 2.  The evolving role of MRI in oncohaematological disorders.

Authors:  O Tamburrini; M A Cova; D Console; P Martingano
Journal:  Radiol Med       Date:  2007-07-24       Impact factor: 3.469

3.  Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma.

Authors:  Patric Kröpil; Roland Fenk; Lars B Fritz; Dirk Blondin; Guido Kobbe; Ulrich Mödder; Mathias Cohnen
Journal:  Eur Radiol       Date:  2007-10-09       Impact factor: 5.315

Review 4.  [Fracture diagnosis in osteoporosis].

Authors:  J S Bauer; D Müller; E J Rummeny; T M Link
Journal:  Radiologe       Date:  2006-10       Impact factor: 0.635

Review 5.  Radiologic assessment of osteoporotic vertebral fractures: diagnostic and prognostic implications.

Authors:  Thomas M Link; Giuseppe Guglielmi; Cornelis van Kuijk; Judith E Adams
Journal:  Eur Radiol       Date:  2005-04-20       Impact factor: 5.315

6.  Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results.

Authors:  Cristina Nanni; Elena Zamagni; Mohsen Farsad; Paolo Castellucci; Patrizia Tosi; Delia Cangini; Eugenio Salizzoni; Romeo Canini; Michele Cavo; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-02       Impact factor: 9.236

Review 7.  Multiple myeloma.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2010-02-11       Impact factor: 3.909

8.  Role of whole-body 64-slice multidetector computed tomography in treatment planning for multiple myeloma.

Authors:  Ahmed Abdel Khalek Abdel Razek; Amany Ezzat; Emad Azmy; Nehal Tharwat
Journal:  Radiol Med       Date:  2012-09-17       Impact factor: 3.469

9.  Clinical significance of trabecular bone score for prediction of pathologic fracture risk in patients with multiple myeloma.

Authors:  Eun Mi Lee; Bukyung Kim
Journal:  Osteoporos Sarcopenia       Date:  2018-06-11

Review 10.  Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma.

Authors:  Susanne Lütje; Jacky W J de Rooy; Sandra Croockewit; Emmeline Koedam; Wim J G Oyen; Reinier A Raymakers
Journal:  Ann Hematol       Date:  2009-12       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.